• Study Comparing [68Ga]Ga-PentixaFor PET/CT and AVS for Diagnosing Primary Aldosteronism in Patients with Hypertension

    Recruiting

    4 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands
  • Long-Term Safety Study of Dabrafenib Mesylate and Trametinib Dimethyl Sulfoxide for Patients Benefiting from Previous Treatment in Multiple Indications

    Recruiting

    3 1 1 1
    Austria Czechia Denmark France Germany Hungary +2
  • Study for Children and Adolescents with Recurrent or Relapsed Solid Tumors Using Lutetium (177Lu) Oxodotreotide and Olaparib

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Spain
  • Study on the Effects of Amikacin Sulfate and Protective Isolation in Critically Ill Neutropenic Patients with Sepsis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study on the Safety and Effectiveness of Afatinib for Fanconi Anemia Patients with Advanced Squamous Cell Carcinoma in the Oral Cavity, Oropharynx, Hypopharynx, or Larynx

    Recruiting

    2 1 1 1
    Investigated Drugs:
    Germany Spain
  • Study on Antithrombin III Human for Patients with Heparin Resistance Undergoing Cardiac Surgery with Cardiopulmonary Bypass

    Recruiting

    3 1 1
    Austria Czechia France Lithuania Poland Romania +2
  • Study on the Effect of Durvalumab and Tremelimumab with Radioactive Glass Spheres in Patients with Non-Resectable Liver Cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    Germany Italy
  • Study on the Use of Human Apotransferrin for Treating Patients with Atransferrinemia

    Recruiting

    2 1 1
    Investigated Drugs:
    Germany Italy Spain
  • Study on Stopping or Continuing Clopidogrel, Carbasalate Calcium, and Dipyridamole for Young Patients After Stroke Without a Known Cause

    Recruiting

    3 1 1 1
    Investigated Diseases:
    The Netherlands
  • Study on Cannabidiol and Dronabinol for Children with Refractory Epilepsy

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands

powered by